Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

iden's campaign "offered few specifics about who would serve on the panel or how the campaign had settled on the idea." The Washington Pact (10/22, Linskey, 14.2M) says Biden "has repeatedly avoided saying directly whether he would accept a court expansion plan promoted by Democrats angry at Republicans

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

shingtonpost.com/politics/biden-promises-commission-on-overhauling-supreme- court/2020/10/22/4465ead6-121d-lleb-ba42-ec6a580836ed_story.html> (10/22, Linskey, 14.2M) says Biden "has repeatedly avoided saying directly whether he would accept a court expansion plan promoted by Democrats angry at Republican

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

iden's campaign "offered few specifics about who would serve on the panel or how the campaign had settled on the idea." The Washington Post (10/22, Linskey, 14.2M) says Biden "has repeatedly avoided saying directly whether he would accept a court expansion plan promoted by Democrats angry at EFTA001484